Protagonist Therapeutics ... (PTGX)
NASDAQ: PTGX
· Real-Time Price · USD
56.01
1.02 (1.85%)
At close: Aug 15, 2025, 12:40 PM
Protagonist Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for PTGX stock have an median target of 70, with a low estimate of 57 and a high estimate of 80. The median target predicts an increase of 24.98% from the current stock price of 56.01.
Target | Low | Average | Median | High |
---|---|---|---|---|
Price | 57 | 69.11 | 70 | 80 |
Change | 1.77% | 23.39% | 24.98% | 42.83% |
Latest Analyst Insight Report
HC Wainwright & Co. maintains a Buy rating on Prot... Unlock content with Pro Subscription
Updated Jun 03, 2025
Rating | Feb 25 | Mar 25 | Apr 25 | May 25 | Jun 25 | Aug 25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 0 | 0 | 0 | 0 |
Buy | 3 | 6 | 1 | 1 | 2 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 8 | 1 | 1 | 2 | 1 |
Financial Forecast this Year
Revenue This Year
64.03M
from 434.43M
Increased by -85.3%
Revenue Next Year
201.13M
from 64.03M
Increased by 214.1%
EPS This Year
-1.71
from 4.47
Increased by 61.7%
EPS Next Year
-0.11
from -1.71
Increased by 93.6%